glutathione metal binding to ligands: Cadmium complexes with revisited glutathione S-transferase

In: Worsfold P, Townshend A, Poole C, editors

Issa G, Bidikin A, Venugopal S, Konopleva M, DiNardo C, Kadia T, Borthakur G , Jabbour E, Pemmaraju N, Yilmaz M, Short N, Maiti A, Sasaki K, Masarova L, Pierce S, Takashi K, Tang G, Loghavi S, Patel K, Andreeff M, Bhalla K, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N

MeHg can interact with GSH to form a GS-MeHg complex (Ballatori and Clarkson 1982), which significantly suppresses the levels of active GSH manifested by increased oxidative stress (Antunes dos Santos et al

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimers disease

Important distinction: "Legal to compound" under 503A is NOT the same as "FDA approved." An FDA-approved drug has gone through full clinical trials and received a New Drug Application (NDA) approval